Bei Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bei Zhao has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Hai-Rong Zeng
Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
1 shared publication- Hairong Zeng
Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research Shanghai University of Traditional Chinese Medicine Shanghai China
1 shared publication Hao-Yue Zhang
Institute of Colorectal Disease Center of Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Traditional Chinese Medicine, Nanjing 210000, China
1 shared publication- Huang Siqing
Department of Oncology, Yue yang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200080, China
1 shared publication Hui-Ting Zhu
Institute of Colorectal Disease Center of Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Traditional Chinese Medicine, Nanjing 210000, China; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
1 shared publicationHui-Zhen Wei
Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
1 shared publication
Latest Publications
- Open Access
- 22 May 2024
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 28 (10) , e18239
Puerarin mitigated LPS‐ATP or HG‐primed endothelial cells damage and diabetes‐associated cardiovascular disease via ROS‐NLRP3 signalling
The occurrence and development of diabetic vascular diseases are closely linked to inflammation‐induced endothelial dysfunction. Puerarin (Pue), the primary component of Pueraria lobata, possesses potent anti‐inflammatory properties. However, its vasoprotective role remains elusive. Therefore, we investigated whether Pue can effectively protect against vascular damage induced by diabetes. In the study, Pue ameliorated lipopolysaccharide‐adenosine triphosphate (LPS‐ATP) or HG‐primed cytotoxicity and apoptosis, while inhibited reactive oxygen species (ROS)‐mediated NLR family pyrin domain containing 3 (NLRP3) inflammasome in HUVECs, as evidenced by significantly decreased ROS level, NOX4, Caspase‐1 activity and expression of NLRP3, GSDMD, cleaved caspase‐1, IL‐1β and IL‐18. Meanwhile, ROS inducer CoCI2 efficiently weakened the effects of Pue against LPS‐ATP‐primed pyroptosis. In addition, NLRP3 knockdown notably enhanced Pue's ability to suppress pyroptosis in LPS‐ATP‐primed HUVECs, whereas overexpression of NLRP3 reversed the inhibitory effects of Pue. Furthermore, Pue inhibited the expression of ROS and NLRP3 inflammasome‐associated proteins on the aorta in type 2 diabetes mellitus rats. Our findings indicated that Pue might ameliorate LPS‐ATP or HG‐primed damage in HUVECs by inactivating the ROS‐NLRP3 signalling pathway.
- 22 May 2024
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 28 (10) , e18239
Open AccessPuerarin mitigated LPS‐ATP or HG‐primed endothelial cells damage and diabetes‐associated cardiovascular disease via ROS‐NLRP3 signalling
The occurrence and development of diabetic vascular diseases are closely linked to inflammation‐induced endothelial dysfunction. Puerarin (Pue), the primary component of Pueraria lobata, possesses potent anti‐inflammatory properties. However, its vasoprotective role remains elusive. Therefore, we investigated whether Pue can effectively protect against vascular damage induced by diabetes. In the study, Pue ameliorated lipopolysaccharide‐adenosine triphosphate (LPS‐ATP) or HG‐primed cytotoxicity and apoptosis, while inhibited reactive oxygen species (ROS)‐mediated NLR family pyrin domain containing 3 (NLRP3) inflammasome in HUVECs, as evidenced by significantly decreased ROS level, NOX4, Caspase‐1 activity and expression of NLRP3, GSDMD, cleaved caspase‐1, IL‐1β and IL‐18. Meanwhile, ROS inducer CoCI2 efficiently weakened the effects of Pue against LPS‐ATP‐primed pyroptosis. In addition, NLRP3 knockdown notably enhanced Pue's ability to suppress pyroptosis in LPS‐ATP‐primed HUVECs, whereas overexpression of NLRP3 reversed the inhibitory effects of Pue. Furthermore, Pue inhibited the expression of ROS and NLRP3 inflammasome‐associated proteins on the aorta in type 2 diabetes mellitus rats. Our findings indicated that Pue might ameliorate LPS‐ATP or HG‐primed damage in HUVECs by inactivating the ROS‐NLRP3 signalling pathway.
- 11 December 2022
- Published by Elsevier in Phytomedicine
- Vol. 109, 154601
Andrographolide promoted ferroptosis to repress the development of non-small cell lung cancer through activation of the mitochondrial dysfunction
- 11 December 2022
- Published by Elsevier in Phytomedicine
- Vol. 109, 154601
Andrographolide promoted ferroptosis to repress the development of non-small cell lung cancer through activation of the mitochondrial dysfunction
- 13 September 2022
- Published by Elsevier in Phytomedicine
- Vol. 107, 154455
Tongxie-Yaofang formula regulated macrophage polarization to ameliorate DSS-induced colitis via NF-κB/NLRP3 signaling pathway
- 13 September 2022
- Published by Elsevier in Phytomedicine
- Vol. 107, 154455
Tongxie-Yaofang formula regulated macrophage polarization to ameliorate DSS-induced colitis via NF-κB/NLRP3 signaling pathway